August 2017 - Volume 23 - Issue 8 - Contributor Index

Author:
Achim, Anca MD

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

Buisson, Anthony; Gonzalez, Florent; Poullenot, Florian; More

Inflammatory Bowel Diseases . 23(8):1425-1433, August 2017.

Author:
Afif, Waqqas MD

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris, Mariam; Bosó, Virginia; Navarro, Belén; More

Inflammatory Bowel Diseases . 23(8):1454-1460, August 2017.

Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study

Al-Darmaki, Ahmed; Hubbard, James; Seow, Cynthia H.; More

Inflammatory Bowel Diseases . 23(8):1272-1277, August 2017.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; More

Inflammatory Bowel Diseases . 23(8):1394-1402, August 2017.

Author:
Algaba, Alicia

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; More

Inflammatory Bowel Diseases . 23(8):1394-1402, August 2017.

Hydrodynamic IL10 Gene Transfer in Human Colon: Results from an “EX VIVO” Study with Potential Clinical Application in Crohn's Disease

Frasson, Matteo; Sendra, Luis; Miguel, Antonio; More

Inflammatory Bowel Diseases . 23(8):1360-1370, August 2017.

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

Liefferinckx, Claire; Minsart, Charlotte; Toubeau, Jean-François; More

Inflammatory Bowel Diseases . 23(8):1371-1381, August 2017.

Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence?

Lopes, Susana; Andrade, Patricia; Conde, Silvia; More

Inflammatory Bowel Diseases . 23(8):1278-1284, August 2017.

Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study

Lopez, Robert N.; Evans, Helen M.; Appleton, Laura; More

Inflammatory Bowel Diseases . 23(8):1418-1424, August 2017.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; More

Inflammatory Bowel Diseases . 23(8):1394-1402, August 2017.

Author:
Arias, Lara MD

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; More

Inflammatory Bowel Diseases . 23(8):1394-1402, August 2017.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; More

Inflammatory Bowel Diseases . 23(8):1394-1402, August 2017.

Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis

Voskens, Caroline J.; Fischer, Anika; Roessner, Susanne; More

Inflammatory Bowel Diseases . 23(8):1348-1359, August 2017.

Author:
Atreya, Raja MD

Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis

Voskens, Caroline J.; Fischer, Anika; Roessner, Susanne; More

Inflammatory Bowel Diseases . 23(8):1348-1359, August 2017.